Stifel reports 3% increase in total client assets for May 2025

Stifel Financial Corp. reported a 3% month-over-month increase in total client assets to $501.4 billion in May, driven by recruiting and market appreciation, alongside a 4% rise in fee-based assets. While the firm achieved record first-quarter revenue, its Q1 2025 EPS significantly missed expectations due to a $180 million legal charge, and it anticipates a 10% year-over-year decline in Q2 investment banking revenue. Despite these challenges, Stifel's CEO remains "cautiously optimistic" for the full year, bolstered by strategic initiatives like the Bryan, Garnier & Co. acquisition aimed at strengthening its global investment banking presence, and a recent Wolfe Research upgrade to Outperform.

Analysis

Stifel Financial Corp. (SF) presents a mixed but fundamentally solid operational picture. The firm reported strong asset gathering, with total client assets increasing 3% month-over-month to $501.4 billion in May 2025, an 8% year-over-year gain. This growth is underpinned by a 13% YoY rise in fee-based client assets, signaling strength in its core wealth management business. However, the firm's recent financial performance is clouded by short-term challenges. A significant one-time $180 million legal charge caused first-quarter 2025 earnings per share of $0.49 to fall dramatically short of the $1.74 consensus, masking what was otherwise a record-high Q1 revenue of $1.26 billion. Looking ahead, Stifel anticipates a near-term headwind in its investment banking division, forecasting an approximate 10% year-over-year revenue decline for Q2 2025 due to market volatility. Despite this, management remains "cautiously optimistic" for the full year, a view supported by strategic initiatives such as the acquisition of European investment bank Bryan, Garnier & Co. to bolster its technology and healthcare verticals, and a recent stock upgrade to "Outperform" by Wolfe Research with a $108 price target.

Key Decisions for Investors

• Investors should consider normalizing Q1 earnings by excluding the $180 million legal charge to assess the firm's core profitability against its strong underlying asset and revenue growth.
• Monitor investment banking activity and revenue trends closely in the second half of the year, as a stabilization or recovery in this segment is crucial to meeting the management's cautiously optimistic full-year outlook.
• Evaluate the successful integration of the Bryan, Garnier & Co. acquisition and its contribution to European revenue, as this is a key pillar of the firm's long-term growth strategy in the middle market.
• Factor in the recent management transition and the Wolfe Research price target of $108 when assessing the stock's current valuation and future potential.